Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.00149634 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Toxoplasma gondii | beta-tubulin, putative | 0.00149634 | 0.5 | 0.5 |
Schistosoma mansoni | tubulin subunit beta | 0.00149634 | 0.5 | 0.5 |
Giardia lamblia | Beta tubulin | 0.00149634 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.00149634 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Echinococcus multilocularis | tubulin beta 1 chain | 0.00149634 | 0.5 | 0.5 |
Loa Loa (eye worm) | beta-tubulin | 0.00149634 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.00149634 | 0.5 | 0.5 |
Toxoplasma gondii | beta-1 tubulin, putative | 0.00149634 | 0.5 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Brugia malayi | beta-tubulin, identical | 0.00149634 | 0.5 | 0.5 |
Trichomonas vaginalis | tubulin, putative | 0.00149634 | 0.5 | 0.5 |
Echinococcus multilocularis | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.00149634 | 0.5 | 0.5 |
Schistosoma mansoni | tubulin subunit beta | 0.00149634 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.00149634 | 0.5 | 0.5 |
Entamoeba histolytica | tubulin family protein | 0.00149634 | 0.5 | 0.5 |
Schistosoma mansoni | tubulin subunit beta | 0.00149634 | 0.5 | 0.5 |
Echinococcus granulosus | tubulin beta 1 chain | 0.00149634 | 0.5 | 0.5 |
Trypanosoma cruzi | beta tubulin, putative | 0.00149634 | 0.5 | 0.5 |
Giardia lamblia | Beta tubulin | 0.00149634 | 0.5 | 0.5 |
Trichomonas vaginalis | tubulin epsilon chain, putative | 0.00149634 | 0.5 | 0.5 |
Giardia lamblia | Beta tubulin | 0.00149634 | 0.5 | 0.5 |
Echinococcus granulosus | tubulin subunit beta | 0.00149634 | 0.5 | 0.5 |
Echinococcus granulosus | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Echinococcus granulosus | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Loa Loa (eye worm) | tubulin beta-4 chain | 0.00149634 | 0.5 | 0.5 |
Schistosoma mansoni | tubulin subunit beta | 0.00149634 | 0.5 | 0.5 |
Loa Loa (eye worm) | BEN-1 protein | 0.00149634 | 0.5 | 0.5 |
Echinococcus multilocularis | tubulin, beta 4A class IVa | 0.00149634 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Echinococcus granulosus | tubulin beta 4A class IVa | 0.00149634 | 0.5 | 0.5 |
Toxoplasma gondii | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Brugia malayi | Tubulin beta-1 chain | 0.00149634 | 0.5 | 0.5 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.00149634 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Echinococcus multilocularis | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Entamoeba histolytica | tubulin family protein | 0.00149634 | 0.5 | 0.5 |
Loa Loa (eye worm) | tubulin beta-2A chain | 0.00149634 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Plasmodium vivax | tubulin beta chain, putative | 0.00149634 | 0.5 | 0.5 |
Loa Loa (eye worm) | BEN-1 protein | 0.00149634 | 0.5 | 0.5 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.00149634 | 0.5 | 0.5 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.00149634 | 0.5 | 0.5 |
Trichomonas vaginalis | tubulin alpha chain, putative | 0.00149634 | 0.5 | 0.5 |
Loa Loa (eye worm) | tubulin beta chain | 0.00149634 | 0.5 | 0.5 |
Echinococcus multilocularis | Tubulin beta 2C chain | 0.00149634 | 0.5 | 0.5 |
Loa Loa (eye worm) | tubulin beta-1 chain | 0.00149634 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Trypanosoma brucei | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.00149634 | 0.5 | 0.5 |
Plasmodium falciparum | tubulin beta chain | 0.00149634 | 0.5 | 0.5 |
Schistosoma mansoni | tubulin subunit beta | 0.00149634 | 0.5 | 0.5 |
Trichomonas vaginalis | tubulin gamma chain, putative | 0.00149634 | 0.5 | 0.5 |
Leishmania major | beta tubulin | 0.00149634 | 0.5 | 0.5 |
Trichomonas vaginalis | tubulin beta chain, putative | 0.00149634 | 0.5 | 0.5 |
Schistosoma mansoni | tubulin subunit beta | 0.00149634 | 0.5 | 0.5 |
Echinococcus multilocularis | tubulin subunit beta | 0.00149634 | 0.5 | 0.5 |
Echinococcus granulosus | Tubulin beta 2C chain | 0.00149634 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 1.7 nM | Antimalarial activity against atovaquone-resistant clinical isolate Plasmodium falciparum TM90-C2B infected in human red blood cells assessed as suppression of parasitemia after 72 hrs by SYBR Green I-based fluorescence method | ChEMBL. | 24720377 |
ED50 (functional) | = 0.1 mg/kg/day | Antimalarial activity against Plasmodium yoelii MR4 MRA-428 infected in mouse CF1 assessed as reduction on parasite burden administered through oral gavage once daily for 4 days | ChEMBL. | 24720377 |
IC50 (ADMET) | > 10 uM | Cytotoxicity against human HepG2 cells after 24 hrs incubation by Alamar Blue assay | ChEMBL. | 24720377 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 24720377 | |
Plasmodium falciparum | ChEMBL23 | 24720377 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.